Charles River Laboratories (Massachusetts) Opens State-of-the-Art Preclinical Services Facility in Massachusetts

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE:CRL) hosted a customer open house at its new, state-of-the-art preclinical services facility in Shrewsbury, Massachusetts. Representatives from leading biotech and pharmaceutical companies in the Northeast were invited to tour the 450,000 square foot facility. Custom-designed for optimal work flow, this new facility will enable flexible and more rapid study starts for both discovery and development programs.

MORE ON THIS TOPIC